Race-dependent association of clinical trial participation with improved outcomes for high-risk prostate cancer patients treated in the modern era. Read more about Race-dependent association of clinical trial participation with improved outcomes for high-risk prostate cancer patients treated in the modern era.
Correction to: Association between adherence to radiation therapy quality metrics and patient reported outcomes in prostate cancer. Read more about Correction to: Association between adherence to radiation therapy quality metrics and patient reported outcomes in prostate cancer.
The natural history of a delayed detectable PSA after radical prostatectomy. Read more about The natural history of a delayed detectable PSA after radical prostatectomy.
Sleep disturbances are underappreciated in prostate cancer survivorship. Read more about Sleep disturbances are underappreciated in prostate cancer survivorship.
Prostate volume, baseline urinary function, and their association with treatment choice and post-treatment urinary function in men treated for localized prostate cancer. Read more about Prostate volume, baseline urinary function, and their association with treatment choice and post-treatment urinary function in men treated for localized prostate cancer.
Acute effect of high-intensity interval aerobic exercise on serum myokine levels and resulting tumour-suppressive effect in trained patients with advanced prostate cancer. Read more about Acute effect of high-intensity interval aerobic exercise on serum myokine levels and resulting tumour-suppressive effect in trained patients with advanced prostate cancer.
Clinical characteristics associated with falls in patients with non-metastatic castration-resistant prostate cancer treated with apalutamide. Read more about Clinical characteristics associated with falls in patients with non-metastatic castration-resistant prostate cancer treated with apalutamide.
Is time to castration resistant prostate cancer a potential intermediate end-point for time to metastasis among men initiating androgen deprivation therapy for non-metastatic prostate cancer with rapid PSA doubling time (<9 months)? Read more about Is time to castration resistant prostate cancer a potential intermediate end-point for time to metastasis among men initiating androgen deprivation therapy for non-metastatic prostate cancer with rapid PSA doubling time (
Risk of progression following a negative biopsy in prostate cancer active surveillance. Read more about Risk of progression following a negative biopsy in prostate cancer active surveillance.
Systematic review of the impact of a plant-based diet on prostate cancer incidence and outcomes. Read more about Systematic review of the impact of a plant-based diet on prostate cancer incidence and outcomes.
